The ability to modulate the volume of the future liver remnant is now a core and indispensable component of oncologic hepatobiliary surgery. Until recently there was general consensus that percutaneous portal vein embolization (PVE) represented the standard for safe and effective generation of future liver remnant hypertrophy.1,2 After PVE, the future remnant is exposed to increased portal flow and responds with a compensatory hypertrophy that reliably increases the safety of subsequent contralateral major hepatectomy.
Aloia TA. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Portal Vein Embolization Should Remain the Gold Standard. JAMA Surg. 2015;150(10):927–928. doi:10.1001/jamasurg.2015.1646
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: